Navigating the Business of Biopharma - Insights from Biopharma Boardroom

04 December, 2023 | Monday

Specialised Therapeutics signs exclusive license agreement with CanariaBio for new ovarian cancer therapy

.. First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progression f...

October 13, 2023 | Friday | News

BetaLife wins Cytiva’s first BioChallenge Competition in Southeast Asia

BetaLife wins top prize with its potential to provide regenerative medicines to patients with severe diabetes in Southeast Asia. Cytiva’s BioChall...

June 08, 2023 | Thursday | News

Partner Content

Industry 4.0 for USP 467: Unlocking Lab Productivity Potential
26 September, 2023
Autophagy Signaling Pathways: Therapeutic Targets for Neurodegenerative Diseases
27 July, 2023
Redefining precision medicine with real-time insights
18 July, 2023
Radioligand Binding Assays: From Opiate Receptors to Drug Discovery Mainstay
04 July, 2023
Looking for [Process] Validation in All the Right Places
04 July, 2023
Mass Spectrometry Explained: 5 Application Areas for LC/MS/MS
22 June, 2023
Challenges and strategies for characterization of next-generation bispecific antibodies
22 June, 2023

BioPharma BreakThrough's

Editor Picks

Nobel Prize in Physiology or Medicine 2023 Awarded to Katalin Karikó and Drew Weissman for Advancements in mRNA Vaccine Technology
04 October, 2023
Avantor Launches Special Edition Pink Pipette in Support of Breast Cancer Awareness
03 October, 2023
Sartorius Forms Partnership with SPARTA Biodiscovery on Novel Nanoparticle Analysis Platform
29 September, 2023
Jubilant Radiopharma and Cardiac Imaging Announce Exclusive Mobile Cardiac PET Partnership
02 October, 2023
FDA Approves Biogen’s TOFIDENCE™ (tocilizumab-bavi), a Biosimilar Referencing ACTEMRA®
02 October, 2023
Thailand Emerges as a Hub for Cancer Immunotherapy Talent, Boosting Advanced Research
04 October, 2023

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2023 Biopharma Boardroom. All Rights Reserved.